Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives

Saira J. Khan, Ekta Kapoor, Stephanie S. Faubion, Juliana M. Kling

Research output: Contribution to journalReview articlepeer-review


Vasomotor symptoms affect as many as 80% of midlife women, but only about one in four women receive treatment due to many factors. Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms, and current professional guidelines conclude that the benefits of treatment typically outweigh the risks for healthy, symptomatic women under age 60 years and those within 10 years from their final menstrual period. For women with medical comorbidities, an individualized approach to treatment is recommended. For women who cannot use or choose not to use menopausal hormone therapy, there are many evidence-based non-hormonal options available including pharmacologic therapies. This review aims to summarize treatment options for bothersome vasomotor symptoms to guide clinicians caring for midlife women.

Original languageEnglish (US)
Pages (from-to)273-287
Number of pages15
JournalInternational Journal of Women's Health
StatePublished - 2023


  • menopausal hormone therapy
  • menopause
  • non-hormonal treatments
  • vasomotor symptoms

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology
  • Maternity and Midwifery


Dive into the research topics of 'Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives'. Together they form a unique fingerprint.

Cite this